In a large study, including over 2000 patients with T2DM, higher plasma levels of LRG1 were significantly associated with peripheral artery disease and several cardiovascular risk factors including arterial stiffness, endothelial dysfunction, systolic blood pressure, age, obesity, kidney function and high-sensitivity C-reactive protein (hsCRP). Here, LRG1 is linked to obesity disorder.